Intelligence Profile
Research Papers
There are several key studies exploring MuseCell Treatment, indicating its potential for various therapeutic applications.
Parkinson's Disease: A study published in the Journal of Clinical Medicine in 2026 investigated Muse cells for treatment in Parkinson’s disease. This research highlighted their unique mechanism of action compared to other stem cell therapies. However, details on the study's design and sample size were not provided.
Comparison with MSCs: Another paper from Biogerontology in 2025 explored differences between Muse cells and mesenchymal stem cells (MSCs) concerning healthspan optimization. This study suggested that Muse cells might have distinct advantages, but wasn't explicit about specific clinical endpoints or sample sizes.
Distinct Characteristics: Research from Frontiers in Bioengineering and Biotechnology in 2025 described Muse cells as unique, macrophage- and pluripotent-like reparative cells. The study emphasized their distinction from other somatic stem cells, indicating potential for novel therapeutic applications.
In terms of clinical trials, the registry trial (NCT07645989) titled "Registry of Outcomes of Dezawa MuseCells®" is currently recruiting, but it is a registry study, implying it may focus more on observational data collection rather than controlled experimental outcomes.
For comprehensive clinical usage and effectiveness, further trials with detailed methodologies and larger sample sizes are necessary.
This information is for educational purposes only and should not be considered medical advice.